Melissa McBurnie
Chairman at MetabloQ Pty Ltd.
Profile
Melissa McBurnie is currently the Chairman at MetabloQ Pty Ltd.
and the Director at Ankere Therapeutics.
She is also a Partner at Brandon Capital Partners Pty Ltd.
Dr. McBurnie has a graduate degree from the University of Adelaide and an MBA from the same institution.
Melissa McBurnie active positions
Companies | Position | Start |
---|---|---|
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Private Equity Investor | 2007-12-31 |
MetabloQ Pty Ltd.
MetabloQ Pty Ltd. BiotechnologyHealth Technology MetabloQ Pty Ltd. develops drugs for cancer treatment. It treats triple-negative breast cancer, prostate cancer and melanoma cancer diseases. The company was founded in 2016 and is headquartered in Melbourne, Australia. | Chairman | - |
Ankere Therapeutics
Ankere Therapeutics BiotechnologyHealth Technology Ankere Therapeutics develops therapeutics for inflammatory diseases. The Australian company was founded by Stuart Pitson, Bernard Flynn. Bernard Flynn has been the CEO since incorporation. | Director/Board Member | - |
Training of Melissa McBurnie
University of Adelaide | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Finance |
MetabloQ Pty Ltd.
MetabloQ Pty Ltd. BiotechnologyHealth Technology MetabloQ Pty Ltd. develops drugs for cancer treatment. It treats triple-negative breast cancer, prostate cancer and melanoma cancer diseases. The company was founded in 2016 and is headquartered in Melbourne, Australia. | Health Technology |
Ankere Therapeutics
Ankere Therapeutics BiotechnologyHealth Technology Ankere Therapeutics develops therapeutics for inflammatory diseases. The Australian company was founded by Stuart Pitson, Bernard Flynn. Bernard Flynn has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Melissa McBurnie